Company Overview
At Clinion, we stand at the forefront of clinical trial innovation, setting the standard for excellence in the field. As a leading provider of clinical trial technology, we empower researchers to navigate the intricacies of the entire clinical trial lifecycle with unparalleled efficiency and accuracy.
Our Vision
At Clinion, our mission is to empower CROs and sponsors in achieving clinical trial success through innovative AI-powered eClinical solutions. We are committed to reducing time to market and increasing ROI for our clients. By consistently delivering timely solutions, prioritizing transparent communication, and providing exceptional customer support, we aim to drive positive change in the industry and make a lasting impact on the world.
Our Mission
At Clinion, our mission is to empower CROs and sponsors in achieving clinical trial success through innovative AI-powered eClinical solutions. We are committed to reducing time to market and increasing ROI for our clients. By consistently delivering timely solutions, prioritizing transparent communication, and providing exceptional customer support, we aim to drive positive change in the industry and make a lasting impact on the world.
History
Our History
2014
The first version of our core platform, Clinion Electronic Data Capture (EDC), was released, marking our official entry into the clinical trial technology market.
2016
We launched version 2.0 of Clinion EDC while achieving significant market adoption. During this year, we partnered with over 10 new clients in India and supported more than 50 studies on our platform.
2018
Continuing our focus on product evolution, we released version 3.0 of Clinion EDC, introducing new features and performance improvements to support more complex trial designs.
2020
Our product suite expanded with the launch of Clinion RTSM 1.0, providing integrated Randomization and Trial Supply Management capabilities to streamline study logistics for our clients.
2021
Our platform was utilized for the Covaxin Phase I/II trial with a rapid deployment. This work supported a successful data submission that led to the approval for Phase II/III trials.
2022
A year of major expansion, we launched Clinion ePRO 1.0 and introduced our first AI feature for medical coding. We also supported a remote trial of 14,000 subjects in India using our integrated eConsent and ePRO mobile application.
2023
Building on our experience in public health, we supported the execution of over 70 COVID-19 studies and more than 20 separate vaccine trials throughout the year.
2024
Our commitment to innovation continued with the release of eight new AI use cases and the launch of Clinion eSource 1.0. Our contributions were recognized with awards from Frost & Sullivan, SCDM, and Clinical Trials Arena.
2025
Our industry recognition continued this year with awards from the ACDM and Citeline. This reflects our cumulative impact, having now supported over 100 customers across 100+ countries. To date, our work spans 655+ trials—including over 150 Biotech, 150 FDA, 100 Medtech, and 100 EMA studies—accelerating research for 300,000 subjects from Phase I to IV.
Leadership
Meet the leadership team
Careers
Find your new team
Clinion offers a challenging work atmosphere where the individual is nurtured into a leader and a doer. We value and reward innovation, integrity, and commitment from our employees. We require people for the following positions
Awards & Recognitions
Achievements in Clinical Excellence
Unlock the Future of Clinical Trials with Clinion.
Cut your trial costs by 35% and accelerate your time-to-market by 30%
Compliance
Fully Compliant with Global Standards
